Endo International | ENDP - Lucro Bruto Sobre Vendas



Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 12.54B 474M 2026-03
Amarin USD 23.17M 961K 2025-12
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Ligand Pharmaceuticals USD 48.45M 8.22M 2026-03
Merck USD 10.85B 2.57B 2025-12
Novartis USD 11.24B 1.18B 2026-06
Pacira USD 126.64M 15.61M 2026-03
Perrigo USD 325.5M 36.7M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Takeda JPY 813.22B 124.39B 2026-06
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Xeris Pharmaceuticals USD 72.55M 404K 2026-03
Zoetis USD 1.62B 20M 2026-03